WellGen secures $3m for obesity nutrigenomics research WellGen secures $3m for obesity nutrigenomics research 16-Feb-2006 By Jess Halliday WellGen has secured $3 million in series B financing, which it will use to fund human clinical trials of its ingredients developed through nutrigenomics to target obesity and inflammation.
